Paul Hastings lands at startup aimed at cancer’s ‘natural killer’ – San Francisco Business Times
San Francisco Business Times |
Paul Hastings lands at startup aimed at cancer's 'natural killer'
San Francisco Business Times Cancer immunotherapy has seen breakthrough successes through checkpoint inhibitors, which unmask cancer cells hiding out from the immune system, and CAR-T, or chimeric antigen receptor T cells, where infection-fighting T cells are engineered to seek … |
